On evaluating the anti-inflammatory activity, it was seen that gallic acid and rutin exhibited very good activity whereas quercetin exhibited better antinociceptive activity than that of standard drug
For instance, the American Diabetes Association only recommends the use of GLP-1 drugs for weight loss for those with a body mass index, or BMI, of at least 30, or among those with a BMI of 27 or greater if they have at least one other condition such as type 2 diabetes, hypertension or high cholesterol
A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society explicitly states that restrictive eating disorder is a general contraindication to GLP-1 use and that individuals with a history of eating disorders should be referred to an eating disorders specialist before these medications are prescribed ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )
Phase II of metabolism may or may not be preceded by Phase I reactions
What to Expect When Beginning GLP-1 Peptide Therapy Treatment begins gradually